Dra. Ana María Estrada Sánchez
Investigadora Titular "A"
Integrante del SNI. Nivel 2
División de Biología Molecular
+52 (444)
4096
+52 (444) 8342000
1.-Estrada-Sánchez AM, Bunner DK, Rebec GV Huntington´s disease and dementia: from genetic models to molecular neuropathology,Diet and Nutrition in Dementia and Cognitive Decline, Academic Press, Inc ,Pp. 77-90.·E.U.A.· ,2015
2.-Victor Manuel Ruiz-Rodríguez, Eneida Turiján-Espinoza, Jaime Arturo Guel-Pañola, Mariana Haydee García-Hernández, José de Jesús Zermeño-Nava, Nallely López-López, Sofia Bernal-Silva, Esther Layseca-Espinosa, Ezequiel M Fuentes-Pananá, Ana María Estrada-Sá Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Recepto,Chemo-Radiation-Resistance in Cancer Therapy, Frontiers Media SA ,Pp. 101-113.ISBN Frontiers Media SA, ·Suiza· ,2022
3.-Estrada-Sánchez AM, Massieu L. Role of oxidative stress in the pathogenesis of Huntingtons disease.,Neurodegeneration and Neuroprotective Strategies, Research Signpost ,Pp. . 21-36.·E.U.A.· ,2007
4.-Ares Orlando Cuellar-Santoyo, Victor Manuel Ruiz-Rodríguez, Teresa Belem Mares-Barbosa, Araceli Patrón-Soberano, Andrew G. Howe, Diana Patricia Portales-Pérez, Amaya Miquelajáuregui Graf, Ana María Estrada-Sánchez Revealing the contribution of astrocytes to glutamatergic neuronal transmission,Physiology and Pathology of Neuroglia, Frontiers Media S.A. ,ISBN 978-2-8325-3148-8, ·Francia· ,2023
5.-Estrada-Sánchez AM, Levine MS, Cepeda C. Epilepsy in other neurodegenerative disorders: Huntingtons and Parkinsons diseases.,Models of seizures and epilepsy, Academic Press, Inc ,Pp. 1043-1058.·E.U.A.· ,2017